Sehouli, J., & Schneeweiss, A. (2014). Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: Results of the randomised phase IIIb CASIMAS study. Medical oncology, 31(8), . https://doi.org/10.1007/s12032-014-0076-7
Chicago Style (17th ed.) CitationSehouli, Jalid, and Andreas Schneeweiss. "Catumaxomab with and Without Prednisolone Premedication for the Treatment of Malignant Ascites Due to Epithelial Cancer: Results of the Randomised Phase IIIb CASIMAS Study." Medical Oncology 31, no. 8 (2014). https://doi.org/10.1007/s12032-014-0076-7.
MLA (9th ed.) CitationSehouli, Jalid, and Andreas Schneeweiss. "Catumaxomab with and Without Prednisolone Premedication for the Treatment of Malignant Ascites Due to Epithelial Cancer: Results of the Randomised Phase IIIb CASIMAS Study." Medical Oncology, vol. 31, no. 8, 2014, https://doi.org/10.1007/s12032-014-0076-7.